EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of potential biomarkers and therapeutic targets for osteoarthritis associated with arginine and proline metabolism based on transcriptome sequencing and bioinformatics

Xiao-Hua Chen, Jun Liu, Ling Qiu, Yang Zhan, Zhuo-Ming Zheng, Peng Chen, You-Xin Su, Jie-Mei Guo, Sheng-Jian Weng

Frontiers in Genetics · 03.07.2026 · 17

DOI: 10.3389/fgene.2026.1795267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 03.07.2026. Verfasst von Xiao-Hua Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou, China. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Osteoarthritis (OA) is a chronic degenerative joint disease. Approximately 300 million people worldwide suffer from OA, which shows a high incidence in middle-aged and elderly populations, with a prevalence of 50% among individuals aged over 60 years. Its core clinical symptoms consist of joint pain, swelling, and dysfunction. Studies have shown that arginine and proline metabolism play an important role in the pathogenesis and progression of OA, but the specific mechanism is still unclear. This study aimed to identify biomarkers and drug therapeutic targets for OA associated with arginine and proline metabolism.

Methods

Synovial tissues of healthy individuals and OA patients were collected for transcriptome sequencing, and the differentially expressed genes (DEGs) between the two groups were compared and analyzed. Arginine and proline metabolism-related genes (APRGs) were obtained from the molecular signature database. The candidate genes were identified by weighted gene co-expression network analysis (WGCNA), and then gene ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis and protein-protein interaction (PPI) were performed. Expression validation was performed using machine learning and ROC analysis to identify key genes. Gene set enrichment analysis (GSEA), immune cell infiltration, and drug prediction were used to explore the mechanism of key genes in OA and potential therapeutic drugs. Finally, clinical samples were experimentally validated through RT-qPCR experiments.

Results

Two hub genes (MYOM2 and TCAP) involved in arginine and proline metabolism were identified. A nomogram constructed based on these genes indicated that MYOM2 and TCAP are key and reliable predictors for osteoarthritis risk. The RT-qPCR experiments on clinical samples showed that the expression levels of these hub genes were significantly downregulated in the synovial tissue of OA patients (p < 0.05), suggesting their potential as diagnostic biomarkers.

Discussion

MYOM2 and TCAP are hub genes in OA metabolism with arginine and proline, which may become new diagnostic markers and potential therapeutic targets for OA.

Schlagwörter

Stichwörter der Autor:innen

arginine and proline metabolismbioinformaticsosteoarthritissynovial tissuetranscriptome sequencing

Autor:innen und Institutionen

  • First Clinical Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • School of Orthopedics and Traumatology, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Department of Orthopedics, The Second General Hospital of Fuzhou, Fuzhou, China.
  • Key Laboratory of Orthopedics & Traumatology of Traditional Chinese Medicine and Rehabilitation, Ministry of Education, Fujian University of Traditional Chinese Medicine, Fuzhou, China.

Förderung

  • Natural Science Foundation of Fujian Province
  • National Key Research and Development Program of China

Zitieren

APA

Chen, X. H., Liu, J., Qiu, L., Zhan, Y., Zheng, Z. M., Chen, P., Su, Y. X., Guo, J. M., & Weng, S. J. (2026). Identification of potential biomarkers and therapeutic targets for osteoarthritis associated with arginine and proline metabolism based on transcriptome sequencing and bioinformatics. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1795267

Vancouver

Chen XH, Liu J, Qiu L, Zhan Y, Zheng ZM, Chen P, et al. Identification of potential biomarkers and therapeutic targets for osteoarthritis associated with arginine and proline metabolism based on transcriptome sequencing and bioinformatics. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1795267

BibTeX
@article{Chen2026,
  author = {Chen, Xiao-Hua and Liu, Jun and Qiu, Ling and Zhan, Yang and Zheng, Zhuo-Ming and Chen, Peng and Su, You-Xin and Guo, Jie-Mei and Weng, Sheng-Jian},
  title = {Identification of potential biomarkers and therapeutic targets for osteoarthritis associated with arginine and proline metabolism based on transcriptome sequencing and bioinformatics},
  journal = {Frontiers in Genetics},
  year = {2026},
  volume = {17},
  doi = {10.3389/fgene.2026.1795267}
}
Kostenlos starten →